Shulan Su

Title: Shulan Su: Innovator in Anti-Colon Cancer Compounds

Introduction

Shulan Su is a notable inventor based in Nanjing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential anti-cancer properties. His work focuses on innovative solutions to combat colon cancer, a prevalent health issue.

Latest Patents

Shulan Su holds a patent for a compound titled "(9beta-H)-pimarane mother nucleus diterpenoid compound with anti-colon cancer activity and derivative thereof." This invention reveals a (9β-H)-pimarane skeleton diterpenoid that exhibits anti-colon cancer activity. The patent also includes a preparation method and application for these compounds. Notably, the invention demonstrates that the novel compounds have significant inhibition effects on colon cancer cells. Specifically, one of the derivatives shows remarkable anti-proliferation effects on two colon cancer cell lines, HT-29 and SW620, surpassing the effects of the positive drug 5-fluorouracil. This discovery positions the compound as a potential candidate for a new anti-colon cancer drug.

Career Highlights

Shulan Su is affiliated with Nanjing University of Chinese Medicine, where he conducts research and development in the field of medicinal compounds. His work has garnered attention for its innovative approach to addressing cancer treatment.

Collaborations

Shulan Su collaborates with esteemed colleagues, including Lu Fan and Cai Lu, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the field of cancer research.

Conclusion

Shulan Su's innovative contributions to the development of anti-colon cancer compounds highlight the importance of research in finding effective treatments for serious health conditions. His work exemplifies the potential of medicinal chemistry to make a significant difference in cancer therapy.